CUPR (Cuprina Holdings (Cayman)) Revenue: $0.04 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CUPR Cuprina Holdings (Cayman) Ltd CUPR
10 GF Score
Price $4.22
! 6 Warning Signs
View Full Analysis

What is Cuprina Holdings (Cayman) Revenue?

Cuprina Holdings (Cayman) CUPR -2.51% 10 Revenue is $0.04 Mil as of Dec. 2025. GuruFocus rates CUPR with a GF Score™ of 10/100. The stock has 6 warning signs investors should review.

Cuprina Holdings (Cayman)'s revenue for the six months ended in Dec. 2025 was $0.02 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2025 was $0.04 Mil. Cuprina Holdings (Cayman)'s Revenue per Share for the six months ended in Dec. 2025 was $0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $0.02.

Warning Sign:

Cuprina Holdings (Cayman) Ltd revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of Cuprina Holdings (Cayman) was 15.40% per year. During the past 3 years, the average Revenue per Share Growth Rate was -2.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 5 years, Cuprina Holdings (Cayman)'s highest 3-Year average Revenue per Share Growth Rate was -2.10% per year. The lowest was -6.70% per year. And the median was -4.40% per year.

Cuprina Holdings (Cayman)  (NAS:CUPR) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Cuprina Holdings (Cayman) Revenue Related Terms

Cuprina Holdings (Cayman) Revenue Historical Data

* Premium members only.

The historical data trend for Cuprina Holdings (Cayman)'s Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cuprina Holdings (Cayman) Revenue Chart

Cuprina Holdings (Cayman) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Revenue
0.04 0.04 0.08 0.04 0.04

Cuprina Holdings (Cayman) Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Revenue Get a 7-Day Free Trial Premium Member Only 0.04 0.03 0.01 0.02 0.02

CUPR vs BNGO, UEEC, FEMY: Revenue Comparison

For the Medical Instruments & Supplies subindustry, Cuprina Holdings (Cayman)'s Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cuprina Holdings (Cayman) Revenue vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cuprina Holdings (Cayman)'s Revenue distribution charts can be found below:

* The bar in red indicates where Cuprina Holdings (Cayman)'s Revenue falls into.


CUPR
10GF Score
Cuprina Holdings (Cayman) Ltd CUPR
Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cuprina Holdings (Cayman) Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Revenue →
What does a Revenue of $0.04 Mil mean?
Cuprina Holdings (Cayman) (CUPR) has a Revenue of $0.04 Mil as of Dec. 2025. Revenue is the total amount a company generates as sales through its operations. View historical data on Cuprina Holdings (Cayman) and its competitors.
Is Cuprina Holdings (Cayman)'s Revenue too high?
Cuprina Holdings (Cayman)'s current Revenue is $0.04 Mil. Overall, Cuprina Holdings (Cayman) has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Cuprina Holdings (Cayman)'s Revenue compare to BNGO and UEEC?
Cuprina Holdings (Cayman)'s Revenue of $0.04 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Cuprina Holdings (Cayman) and its competitors. Cuprina Holdings (Cayman)'s current Revenue is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cuprina Holdings (Cayman) stock overvalued right now?
Cuprina Holdings (Cayman) (CUPR) has a current Revenue of $0.04 Mil. The current Revenue is $0.04 Mil. Cuprina Holdings (Cayman)'s overall GF Score™ is 10/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Cuprina Holdings (Cayman) (CUPR), the current Revenue is $0.04 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cuprina Holdings (Cayman) Business Description

Address c/o Blk 1090 Lower Delta Road No. 06-08, Singapore, SGP, 169201
Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.
10GF Score

Get the complete analysis for CUPR

Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.22
Price